Eric Padron

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 25 papers. Top paper: “Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma”.

Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0177

N/A

3.4DataRank · unranked

75 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Cancer therapy shapes the fitness landscape of clonal hematopoiesis

Nature Genetics(2020)10.1038/s41588-020-00710-0

N/A

0.986DataRank · unranked

717 citations

Ryan Ptashkin, Teng Gao, Lior Z. Braunstein, Sean M. Devlin, Daniel J. Kelly +59 more

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Leukemia(2022)10.1038/s41375-022-01724-9

N/A

0.926DataRank · unranked

28 citations

Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker +44 more

Health-related quality of life and vulnerability among people with myelodysplastic syndromes: a US national study

Blood Advances(2023)10.1182/bloodadvances.2022009000

N/A

0.697DataRank · unranked

16 citations

Donnie Hebert, Cecilia Lee, Dana E. Rollison, Nancy Gillis, Rami S. Komrokji +15 more

Discordant pathologic diagnoses of myelodysplastic neoplasms and their implications for registries and therapies

Blood Advances(2023)10.1182/bloodadvances.2023010061

N/A

0.554DataRank · unranked

12 citations

Michael Otterstatter, Tareq Al Baghdadi, Nancy Gillis, James M. Foran, Jane Jijun Liu +19 more

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

Blood Advances(2023)10.1182/bloodadvances.2022008578

N/A

0.543DataRank · unranked

9 citations

Johannes B. Goll, R. Coleman Lindsley, Rafael Bejar, Steffanie H Wilson, Donnie Hebert +20 more

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

Myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T): Mayo-Moffitt collaborative study of 158 patients

Blood Cancer Journal(2022)10.1038/s41408-022-00622-8

N/A

0DataRank · unranked

20 citations

Terra L. Lasho, Rhett P. Ketterling, Kaaren K. Reichard, Naseema Gangat, Aref Al‐Kali +10 more

SF3B1-mutant myelodysplastic syndrome/myeloproliferative neoplasms: a unique molecular and prognostic entity

Haematologica(2022)10.3324/haematol.2021.280463

N/A

0DataRank · unranked

8 citations

Terra L. Lasho, Christy M. Finke, Rhett P. Ketterling, Kaaren K. Reichard, Kristen McCullough +16 more

Molecular characteristics and outcomes in Hispanic and non‐Hispanic patients with acute myeloid leukemia

eJHaem(2022)10.1002/jha2.589

N/A

0DataRank · unranked

5 citations

Deukwoo Kwon, Jorge Monge, Mikkael A. Sekeres, Namrata S. Chandhok, Amber Thomassen +6 more

Targeting BET Proteins downregulates miR-33a to promote synergy with PIM inhibitors in CMML

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.01.514753

N/A

0DataRank · unranked

0 citations

Maria E. Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose +19 more

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3929

N/A

0DataRank · unranked

5 citations

Maria E. Balasis, Hannah Newman, Moritz Binder, Alexis Vedder, Fumi Kinose +20 more

Validation of Molecular International Prognostic Scoring System (IPSS-M) in myelodysplastic/myeloproliferative neoplasms, not otherwise specified (MDS/MPN-NOS)

Leukemia Research(2023)10.1016/j.leukres.2023.107340

N/A

0DataRank · unranked

2 citations

David M. Swoboda, Terra L. Lasho, Christy M. Finke, Rhett P. Ketterling, Kaaren K. Reichard +4 more

Data from Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

(2023)10.1158/2643-3230.c.6550812.v1

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Risk prediction for clonal cytopenia: multicenter real-world evidence

Blood(2024)10.1182/blood.2024024756

N/A

0DataRank · unranked

50 citations

Rami S. Komrokji, Najla Al‐Ali, Alexandra Regelson, Susan Geyer, Anand Patel +39 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more

Precision preclinical modeling to advance cancer treatment

JNCI Journal of the National Cancer Institute(2024)10.1093/jnci/djae249

N/A

0DataRank · unranked

11 citations

Jesse S. Boehm, Elinor K. Karlsson, Eric Padron, Mukund Seshadri, Deeann Wallis +2 more

Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study

Blood Neoplasia(2024)10.1016/j.bneo.2024.100026

N/A

0DataRank · unranked

1 citations

Johannes B. Goll, Travis L. Jensen, Sridhar Nonavinkere Srivatsan, Nancy Gillis, Gregory A. Abel +14 more

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts

The Lancet Haematology(2020)10.1016/s2352-3026(20)30205-2

N/A

0DataRank · unranked

97 citations

Prajwal Boddu, Mrinal M. Patnaik, Jan Philipp Bewersdorf, Maximilian Stahl, Raajit K. Rampal +47 more

Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS‐CoV‐2 pandemic

American Journal of Hematology(2020)10.1002/ajh.25853

N/A

0DataRank · unranked

10 citations

Terra L. Lasho, Eric Padron, Kristen McCullough, Aref Al‐Kali, Ayalew Tefferi +6 more

RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis

Nature Communications(2021)10.1038/s41467-021-23186-w

N/A

0DataRank · unranked

100 citations

Denis Vorobyev, Terra L. Lasho, David L. Marks, Ezequiel J. Tolosa, Alexis Vedder +30 more

Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromes

Blood Advances(2021)10.1182/bloodadvances.2020003475

N/A

0DataRank · unranked

40 citations

Kathy L. McGraw, Farnoosh Abbas‐Aghababazadeh, Benjamin S. Meyer, Amy F. McLemore, Nicole D. Vincelette +14 more

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.28.461858

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Jungsheng Ma, Romil Patel, Kartik Devashish +32 more

Role of ASXL1 in hematopoiesis and myeloid diseases

Experimental Hematology(2022)10.1016/j.exphem.2022.09.003

N/A

0DataRank · unranked

28 citations

Xiaona You, Nathalie Droin, Lauren Banaszak, Jane E. Churpek, Eric Padron +5 more